An interventional study of Menthol ban + campaign and Menthol ban in Health Behavior, sponsored by University of North Carolina, Chapel Hill. Recruiting at 1 site in United States. Open to participants aged 21 Years and older. Per ClinicalTrials.gov, last updated 2026-04-27.
Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Health Behavior by University of North Carolina, Chapel Hill — 3 open to participants now, 3 under way, none of them phase 3. Health Behavior · University of North Carolina, Chapel Hill.
Among the 10 studies in Health Behavior by University of North Carolina, Chapel Hill, this one is the 2nd largest by planned enrollment, is one of 2 that started in 2026, is one of 10 with no phase, and was the 10th registered.
970 studies on the registry are indexed under Health Behavior; 166 are open to participants now.
Browse Health Behavior studies →3 of the 10 studies in Health Behavior by University of North Carolina, Chapel Hill are open now, in 1 country. Recruiting first, the newest first:
University of North Carolina, Chapel Hill · Sites in United States
Ages 18+ · Healthy volunteers
University of North Carolina, Chapel Hill · Sites in United States
Ages 18–99 · Healthy volunteers
By country, each count listing its studies:
Of the 94 Health Behavior studies recruiting now, 39 (41%) set no upper age limit and 38 (40%) stop at 75 or younger; 25 take children under 18; 59 take healthy volunteers.
This study: 21 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 2 started in 2026.
This study's planned enrollment of 1,185 is above the median of 150 across 826 interventional studies indexed under Health Behavior.
Median enrollment 384 across the 10 interventional studies. Of the 7 that completed or were terminated, 2 (29%) have results posted.
This tab as a report to print or save as PDF → With an account.
University of North Carolina, Chapel Hill is the lead sponsor of 1,373 studies on the registry; 134 are open to participants now.
Of its 162 completed or terminated interventional studies of FDA-regulated products, 140 (86%) have results posted.
1 of the studies in Health Behavior by University of North Carolina, Chapel Hill that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05397951University of North Carolina, Chapel HillThe Validation Study of Bioelectronics | 2026-11 |
Add it to your calendar (.ics) → With an account.
Among the 10 studies in Health Behavior by University of North Carolina, Chapel Hill, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The main purpose of this trial is to evaluate the impact of a menthol cigarette ban accompanied by a quit smoking campaign on tobacco purchasing behavior. Investigators will conduct a randomized clinical trial with \~1,185 US adults (ages 21+ years) who currently smoke menthol cigarettes.
This trial aims to determine whether a quit smoking campaign amplifies the impact of a simulated menthol cigarette ban. The trial will enroll \~1,185 adults ages 21 years and older who currently smoke menthol cigarettes. Participants will attend 2 in-person study visits at our experimental store, spaced approximately 1 week apart. The store will be stocked with a variety of tobacco products, food, non-alcoholic beverages, and household goods. At the first visit, participants will provide written informed consent and will be randomized to 1 of 3 trial arms, described further below. At both study visits, participants will shop for items in the store and complete computer surveys. Researchers will record in-store purchases and other self-reported measures will be assessed via the computer surveys. In between the in-person study visits, participants will receive ads via text message based on their trial arm.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Behavioral: Menthol ban + campaign
Behavioral: Menthol ban
Behavioral: Control
Menthol cigarettes and flavored little cigars and cigarillos will not be available for purchase in the store. Participants will receive quit smoking campaign ads via text message. These ads will also be displayed inside the store during the shopping tasks.
Menthol cigarettes and flavored little cigars and cigarillos will not be available for purchase in the store. Participants will receive control ads about a neutral topic (i.e., password security) via text message. These ads will also be displayed inside the store during the shopping tasks.
Menthol cigarettes and flavored little cigars and cigarillos will be available for purchase in the store. Participants will receive control ads about a neutral topic (i.e., password security) via text message. These ads will also be displayed inside the store during the shopping tasks.
Purchasing any combustible tobacco products
Measured using purchase data for combustible tobacco products, defined as any cigarettes or little cigars and cigarillos. Response options are "No" (coded as 0) and "Yes" (coded as 1).
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Expenditures on combustible tobacco products
Measured using purchase data for combustible tobacco products, defined as any cigarettes or little cigars and cigarillos. This measure is in US dollars, ranging from $0 to $70.
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Purchasing any non-combustible tobacco products (substitution effects)
Measured using purchase data on whether participants bought any non-combustible tobacco products, defined as any e-cigarettes, smokeless tobacco, or nicotine pouches. Response options are "No" (coded as 0) and "Yes" (coded as 1).
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Attempted to quit smoking
Measured using 1 survey item: "In the last week, did you stop smoking cigarettes for 1 day or longer because you were trying to quit smoking?" Response options are "No" coded as 0) and "Yes" (coded as 1).
Time frame: Assessed 1 time, approximately 1 week after enrollment.
Forgoing cigarette use
Measured using 2 survey items (e.g., " In the last week, how often have you stopped yourself from having a cigarette because you wanted to smoke less?"). The 5-point response scale ranges from "Never" coded as 0, to "10 or more times", coded as 10. Researchers will average responses to the 2 survey items to create a scale score. Higher scores indicate greater frequency of forgoing cigarettes.
Time frame: Assessed 1 time, approximately 1 week after enrollment.
Intentions to quit smoking
Measured using 3 survey items (e.g., "How interested are you in quitting smoking cigarettes in the next 4 weeks?"). The 4-point response scale ranges from low intentions (coded as 1) to high intentions (coded as 4). Researchers will average responses to the 3 survey items to create a scale score. Higher scores indicate greater intentions to quit smoking.
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Injunctive norms for quitting smoking
Measured using 3 survey items (e.g., "People who are important to me think I should quit smoking."). The 5-point response scale ranges from "Strongly disagree" (coded as 1) to "Strongly agree" (coded as 5). Researchers will average responses to the 3 survey items to create a scale score. Higher scores indicate greater injunctive norms for quitting smoking.
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Targeted benefits of quitting smoking
Measured using 6 survey items (e.g., "If you were to stop smoking, how likely would you be to get more quality time with loved ones?"). The 5-point response scale ranges from "Not at all likely" (coded as 1) to "Extremely likely" (coded as 5). Researchers will average responses to the 7 survey items to create a scale score. Higher scores indicate greater targeted benefits of quitting smoking.
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Reactance towards cigarette options
Measured using 3 survey items (e.g., "I was annoyed by the cigarette options in the Mini Mart."). The 5-point response scale ranges from "Strongly disagree" (coded as 1) to "Strongly agree" (coded as 5). Researchers will average responses to the 3 survey items to create a scale score. Higher scores indicate greater reactance toward cigarette options.
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Reactance towards ads
Measured using 3 survey items (e.g., "The ads annoyed me."). The 5-point response scale ranging from "Strongly disagree" (coded as 1) to "Strongly agree" (coded as 5). Researchers will average responses to the 3 survey items to create a scale score. Higher scores indicate greater reactance toward ads.
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Stigma from cigarette options
Measured using 1 survey item (i.e., "How much did the cigarette options in the Mini Mart make you feel judged by other people for smoking?"). The 5-point response scale ranges from "Not at all" (coded as 1) to "A great deal" (coded as 5) to create a scale score. Higher scores indicate greater stigma from cigarette options.
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
Stigma from ads
Measured using 1 survey item (i.e., "How much did the ads make you feel judged by other people for smoking?"). The 5-point response scale ranges from "Not at all" (coded as 1) to "A great deal" (coded as 5). Higher scores indicate greater stigma from ads.
Time frame: Assessed 2 times approximately 1-week apart, starting on the day of enrollment.
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Started Apr 2026 (actual). Primary completion is estimated for Apr 2028, 24 months after the start.
Of 569 non-industry interventional studies with no phase under Health Behavior, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 24 months is above that.
Counting every sponsor, half of 587 studies reached it within 15 months; a quarter within 5 and three quarters within 32.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of North Carolina, Chapel Hill →